Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Dysphagia in TBI
NCT06319638Not yet recruiting
- Sponsor
- Copka Sonpashan
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of lidocaine in dysphagia, sponsored by Copka Sonpashan. Primary endpoint: Penetration-Aspiration Scale at day 10. Planned start May 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT06319638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319638.